Richard C Chao

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Replacement Therapy

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Cloud P Paweletz, Grace A Heavey, Yanan Kuang, Emily Durlacher, Thian Kheoh, Richard C Chao, Alexander I Spira, Konstantinos Leventakos, Melissa Lynne Johnson, Sai-Hong Ignatius Ou, Gregory J Riely, Kenna Anderes, Wenjing Yang, James G Christensen, Pasi A Janne
Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sai-Hong Ignatius Ou, Pasi A Janne, Ticiana A Leal, Igor I Rybkin, Joshua K Sabari, Minal A Barve, Lyudmila Bazhenova, Melissa Lynne Johnson, Karen L Velastegui, Cornelius Cilliers, James G Christensen, Xiaohong Yan, Richard C Chao, Kyriakos P Papadopoulos
First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRAS G12C Solid Tumors (KRYSTAL-1). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (23) (2022)
Nicholas P Giustini, Sandip Pravin Patel, Nathaniel J Myall, José Fernando do Prado Moura, Amit A Kulkarni, Richard C Chao, Heather A Wakelee, Lyudmila Bazhenova
Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF : Case Series and Literature Review of Treatment. JCO precision oncology 6 (2022)